US Equities Market News

World Equity News

Equities Org UK

Mortgages, insurance, and loans for the self-employed and students

Equities Org equities news has moved!

How to quickly sell your house

London equity markets make small gains

Eurofirst highest since May 2002

Eurofirst makes small gains as Xetra Dax down

Eurofirst slightly higher as elections approach

London strong on double witching hour

NYSE sees little movement on investor caution

European equities investors worried by elections

NYSE equities down on economic data

Nikkei down on post-election profit-taking

Nikkei down on post-election profit-taking

Economic concerns hit Eurofirst and Xetra Dax

Japanese elections boost Tokyo indices

Xetra Dax sees fall in Allianz

Utilities focus on FTSE

Dow Jones sees little movement

Analysts suggest Katrina will stimulate economy

Investors settled by Japanese polls

Banking and utilities see gains on Eurofirst

FTSE makes small gains on mergers

Investors consider construction boom after hurricane

Investors wait in Sunday's election

Eurofirst drops from 38-month highs

UK Equities down despite monetary policy decision

London FTSE makes only small gains

Investors consider Katrina economy impact

FTSE gains to three-year high


27/05/05

Permalink 07:44:09 pm, Categories: Companies, 191 words  

Pfizer faces FDA over viagra sight losss claims

The US Food and Drug Administration has confirmed that it investigating reports that up to 38 men who used the impotence drug Viagra have suffered vision loss.

Pfizer, the company that makes Viagra and the largest pharmaceuticals group in the world, defended its product, saying that there is no evidence that the type of vision loss reported in the Viagra users is more frequent in users of the drug than it is in men who do not use it.

The company also said that the type of vision loss being reported by users of the drug is common in men over 50 who have conditions like high blood pressure, high cholesterol, and diabetes, conditions that can also cause the impotence problems that Viagra treats.

This, Pfizer claims, makes it impossible to tell whether the drug itself had anything to do with the men’s loss of vision. Notwithstanding their defense of Viagra, Pfizer is in talks with the FDA over the possibility of revising safety warnings on the drug.

Shares of Pfizer lost nearly 2 percent of their value on the New York Stock Exchange Friday after reports of the vision problems were announced.

Permalink

Categories

US Equities


Morocco property investment
Property investment opportunities available in Morocco.
SDH Flannel
Find great deals on SDH bedding products.
sell and rent back
Find how to sell and rent back your property.
Corner shower
Discounted corner showers & bath accessories
Technical schools Find business and tech school course for you


Syndicate this blog XML

 

US Equities copyright 2005 Central Consultants : All Rights Reserved